Skip to main content

Table 2 Therapeutic response at day 28, after PCR adjustment, in vivo study, Dabola

From: Efficacy of antimalarial treatment in Guinea: in vivo study of two artemisinin combination therapies in Dabola and molecular markers of resistance to sulphadoxine-pyrimethamine in N'Zérékoré

Results

AS/AQ (n = 102)

AS/SP (n = 99)

 

N

%

95%CI

N

%

95%CI

Early Treatment failure

0

0

0–3.5

1

1

0–5.5

Late Treatment Failure

1

1.0

0–3.5

0

0

0–3.7

Total failure

1

1.0

0–5.3

1

1.0

0–5.5

ACPR

101

99.0

94.7–99.8

98

99.0

94.5–99.8

  1. Outcome classification according to WHO guidelines [4]
  2. Late Treatment Failure = Late Clinical Failure + Late Parasitological Failure
  3. ACPR: Adequate Clinical and Parasitological Response
  4. Outcome classification is WHO (2003)
Back to article page

Malaria Journal

ISSN: 1475-2875

Contact us